LONDON, - British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such goals in response to the U.S. president's ...

Tony Wood, Chief Scientific Officer, GSK, said: "We are excited about the opportunities ahead to help improve meningococcal vaccination coverage in the United States, especially for IMD caused by ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be intrigued to know that GSK plc (LON:GSK) is about to go ex-dividend in just ...

Commenting on the results, Bhushan Akshikar, MD of GlaxoSmithKline Pharmaceuticals, highlighted the company’s strategic initiatives in strengthening its market presence and enhancing access to ...

GSK's business development team have been working ... which notes that the programme will focus on using Muna's MiND-MAP platform to map the brain's response to the aggregation of proteins like ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

The APAC private wealth management landscape is shifting rapidly as new tools and client demands push the industry toward increased efficiency, accuracy, and competition. Recent discussions and ...

Marriott Vacations Worldwide Corp. (NYSE:VAC) is scheduled to report fourth-quarter 2017 numbers on Feb 27, before the opening ...

GSK (GSK) reported robust earnings for the first quarter, with a 13% increase in sales to £7.4 billion and significant ...

Ryan Chan is a Newsweek reporter based in Hong Kong, where he previously had over a decade of experience at a local newspaper, covering China and current events around the world. His focus is on ...